Evidence map›Paper›PMID 41370352›Full record

ArticleChemistry & biodiversity2026

Four New Alkaloid Heterodimers From Scolopendra subspinipes mutilans.

Bin-Yuan Hu, Cong Fu, Wu-Mei Sun, Yong-Xian Cheng

Abstract read
In one paragraph

Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bin-Yuan HuSchool of Chinese Materia Medica &Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan International Joint Laboratory for Exploration and Utilization of Aromatic Chinese Medicinal Materials in Agriculture, Yunnan University of Chinese Medicine, Kunming, People's Republic of China.
Cong FuGuangdong Provincial Key Laboratory of Chinese Medicine Ingredients and Gut Microbiomics, Institute for Inheritance-Based Innovation of Chinese Medicine, School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, People's Republic of China.
Wu-Mei SunSchool of Chinese Materia Medica &Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan International Joint Laboratory for Exploration and Utilization of Aromatic Chinese Medicinal Materials in Agriculture, Yunnan University of Chinese Medicine, Kunming, People's Republic of China.
Yong-Xian ChengSchool of Chinese Materia Medica &Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan International Joint Laboratory for Exploration and Utilization of Aromatic Chinese Medicinal Materials in Agriculture, Yunnan University of Chinese Medicine, Kunming, People's Republic of China.ORCID https://orcid.org/0000-0003-1643-9598

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three rare pyrazine-containing alkaloid heterodimers scosubspiloids A-C (1-3) and one new spiro-indole heterodimer scosubspiloid D (4), along with seven known alkaloids (5-11) were isolated from Scolopendra subspinipes mutilans. Spectroscopic methods and ECD calculations were used to identify their structures. Biologically, 1-3 could significantly inhibit the proliferation of MDA-MB-231 cells at 20 µM. The investigation provided experimental evidences to support the traditional use of S. subspinipes mutilans in treating cancer, and revealed new structure type compounds in the medicinal animal.

Indexed as

AlkaloidsAntineoplastic AgentsAnimals, PoisonousCell Line, TumorCell ProliferationChilopodaDimerizationDose-Response Relationship, DrugDrug Screening Assays, AntitumorHumansMolecular ConformationMolecular StructureStructure-Activity RelationshipAlkaloidsAntineoplastic Agentsanti‐cancer activityindole alkaloidspyrazineScolopendra subspinipes mutilans

Identifiers

PMID41370352
PMCPMC13420694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.